Evidence map›Paper›PMID 31031741›Full record

ArticleFrontiers in microbiology2019

Optimisation of the Protocol for the LIVE/DEAD

Julia Robertson, Cushla McGoverin, Frédérique Vanholsbeeck, Simon Swift

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Ability ofMicroorganisms · 2026
    Article
  3. Ultrafast-light driven plasmonic inactivation ofJournal of materials chemistry. B · 2026
    Article
  4. HypervirulentMicrobiology spectrum · 2026
    Article
  5. Article
  6. The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  7. Article
  8. Membrane Vesicles ImproveMicroorganisms · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Montelukast treatsMicrobiology spectrum · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julia RobertsonDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
Cushla McGoverinThe Dodd-Walls Centre for Photonic and Quantum Technologies, Auckland, New Zealand.
Frédérique VanholsbeeckThe Dodd-Walls Centre for Photonic and Quantum Technologies, Auckland, New Zealand.
Simon SwiftDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
University of Auckland · NZThe Dodd-Walls Centre for Photonic and Quantum Technologies · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid antimicrobial susceptibility testing is needed to reduce prescription of inappropriate antibiotics. A rapid alternative to standard culture-based testing is to determine reductions in cell viability using the LIVE/DEAD

Indexed as

crosstalkEscherichia colifluorescencepropidium iodideSYTO 9viability

Identifiers

PMID31031741
PMCPMC6474257
OpenAlexW2939631747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.